Sep 30, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test
QDEL boosts its respiratory testing lineup with the FDA-cleared QUICKVUE Influenza + SARS Test for professional use.
Sep 18, 2025 • Zacks Commentary
NEUTRAL
Medtronic ( MDT ) Up 1.5% Since Last Earnings Report: Can It Continue?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Sep 04, 2025 • Benzinga
NEUTRAL
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - QuidelOrtho ( NASDAQ:QDEL )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In QuidelOrtho ( QDEL ) To Contact Him Directly To Discuss Their Options
Aug 21, 2025 • Benzinga
SOMEWHAT-BULLISH
Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities - QuidelOrtho ( NASDAQ:QDEL )
SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- With classrooms once again filled and respiratory virus season beginning, QuidelOrtho Corporation QDEL, a global leader of in vitro diagnostics, is sharing timely public health insights from Dr. Jonathan Temte, Professor of Family Medicine and Community ...
Aug 08, 2025 • Zacks Commentary
BULLISH
Why QuidelOrtho ( QDEL ) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Aug 07, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Should Value Investors Buy QuidelOrtho ( QDEL ) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.